Malaysia’s Medical Device (Amendment) Regulations 2025 [P.U.(A) 330] raise Class A medical device application fees from RM 100 to RM 500 and add a RM 750 registration fee effective 1 January 2026. Manufacturers must submit before 10 December 2025 to keep the current rate. The change supports MDA’s cost-recovery model and strengthens post-market surveillance in Malaysia’s device sector.
Malaysia’s Medical Device Authority (MDA) has announced new application and registration fees for Class A medical devices, effective 1 January 2026, under the Medical Device (Amendment) Regulations 2025 [P.U.(A) 330].
Understanding these changes is crucial for medical device manufacturers planning to register or renew Class A products in Malaysia’s regulated medical device market.
Until 10 December 2025, Class A devices are charged an RM 100 application fee with no registration fee. From 1 January 2026, the following new fee structure applies:
Any application submitted after 10 December 2025 will fall under the new fee schedule. Applications received on or before that date remain eligible for the existing RM 100 rate with no registration charge.
This marks the first increase in Class A device fees since the 2012 Medical Device Regulations. The introduction of a registration fee signals MDA’s shift toward a cost-recovery model, supporting sustainable oversight and post-market surveillance.
For manufacturers, this means:
Manufacturers with multiple Class A devices should assess their portfolios now to optimize submission timing.
For broader context, see also:
The amendment under P.U.(A) 330 revises the Fifth Schedule of the 2012 Regulations, aligning Malaysia’s model with regional cost-recovery practices. Adding a registration fee for Class A devices brings the fee structure closer to that of higher-risk device categories, promoting fairness and funding continuous regulatory monitoring.
The Malaysia MDA Class A Fee Update 2026 increases the application fee to RM 500 and introduces a RM 750 registration fee, effective 1 January 2026.
Manufacturers should submit before 10 December 2025 to retain the lower cost and prepare early for the new regime.
For full details, refer to the official notice: Medical Device (Amendment) Regulations 2025 [P.U.(A) 330]
Browse our news hub featuring company announcements, regulatory updates, and industry insights to keep you informed and ahead of the curve.
Whether looking for more information or ready to partner with us, we're here to guide you through every step of the regulatory process.
Contact us